Evolutionary Genomics, Inc.
FNAM
$0.0002
-$0.0006-75.00%
OTC PK
| 12/31/2022 | 09/30/2022 | 06/30/2022 | 03/31/2022 | 12/31/2021 | |
|---|---|---|---|---|---|
| Net Income | 30.74% | 40.87% | -24.07% | -41.40% | -63.20% |
| Total Depreciation and Amortization | -1.66% | -8.54% | 13.41% | 57.00% | 153.74% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 41.92% | 1,647.98% | 117.06% | 114.36% | 114.37% |
| Change in Net Operating Assets | 122.75% | 1,926.39% | 52.53% | 139.71% | 175.74% |
| Cash from Operations | 59.52% | 69.20% | 30.58% | 36.34% | 31.08% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -100.00% | -30.72% | -37.20% | -31.84% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -36.51% | -65.10% | 15.50% | 4.69% | -31.84% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 19,210.53% | -43.79% | 47,321.05% | 987.11% | -101.12% |